Testmate Health

Testmate Health develops at-home testing solutions, focusing initially on a low-cost, over-the-counter self-test for sexually transmitted infections (STIs) like chlamydia and gonorrhea. Their urine-based DNA platform detection technology provides lab-quality results in under 30 minutes, aiming to increase accessibility and improve STI detection rates.

Funding Round: Seed

Funding Amount: $6M

Date: 08-May-2024

Investors: RH Capital, The Helm, Zürcher Kantonal Bank, Amboy Street Ventures, Lichtsteiner Foundation, Dartlabs.io

Markets: Healthtech, Diagnostics, Biotechnology, Health Care, Health Diagnostics, Life Science, Personal Health, Pharmaceutical

HQ: Lausanne, Vaud, Switzerland

Founded: 2020

Website: https://www.testmatehealth.com/

LinkedIn: https://www.linkedin.com/company/testmatehealth

Twitter: https://x.com/SdcMed

Instagram:

Facebook: https://www.facebook.com/STDtestmate